TNFRSF11A and neoplasm: Treatment of GCTB with denosumab can significantly reduce or eliminate RANK-positive tumor giant cells but only exerts an inhibitory, and not anti-apoptotic effect, on tumor stromal cells, a histological different cell type in GCTB [32,33,34].